FMRFamid-rokon neuropeptidek és receptoraik hatásmechanizmusának genetikai analízise Drosophila melanogaster-ben  =  Insect FMRFamide-related neuropeptides (FaRPs) and receptors: genetic analysis of their mechanism of action in Drosophila melanogaster by Kiss, István et al.
The results described in this report were summarized in a manuscript which has been 
submitted for publication: 
Brigitta Kiss, Tamás Szlanka, Beáta Ramasz, Zoltán Hegedűs, Michal Žurovec, 
Michal Sery, Štefan Kakas, Tamás Lukacsovich, Adrien Fónagy and István Kiss: 
 
Selective elimination/RNAi silencing of FMRFa-related peptides and their receptors 
decreases the locomotor activity in Drosophila melanogaster 
 
(Gen. Comp. Endocrinology, submitted) 
 
The above article as well as another one on the off-target effects will be published during the 
next two years. Therefore, we respectfully ask the OTKA Committee to take this fact into 
consideration when evaluating this closing report on OTKA Grant No. 75774. 
 
 
 
Specific neurons in the central nervous system (CNS) secrete specific peptides which act as 
neurohormones steering vital processes in all Metazoans. Insects as well use a plethora of 
neuropeptides to control physiological, developmental and behavioral events (Nässel and 
Winther, 2010).We accomplished a genetic analysis in Drosophila melanogaster of the 
FMRF-related group of peptides (FARPs) comprising (DMS the dFMRFamide, 
dromyosuppressin) and drosulfakinin (DSK) peptides, and their specific receptors (FP, 
DMS-R1 and -R2, DSK-R1 and –R2).  
In the original OTKA grant application, we planned to accomplish four different genetic 
approaches to study the FMRF-related (FARP) peptides and their specific receptors : (i) 
isolation of intragenic deletion mutants  by P transposon remobilization; (ii) gene silencing 
by double-stranded inhibitory RNA (RNAi); (iii) induction of distinct mutations by 
homologous recombination in each of the 8 peptides coded for by the FMRFa gene; (iv) 
construction of UAS-cDNA transgenes for overexpressing the FARP peptides and 
receptors. We fulfilled the first two tasks, partially did the third one, and implemented a 
new (iv) project, i.e. construction of new Gal4 drivers with DNA fragments from the 5’ 
regulatory sequences of the FMRFa gene. These changes were partly caused by the sudden 
and very sad death in 2011 of  our paticipating colleague, Dr. Géza Ádám (Institute of 
Genetics, Biological Research Centre at Szeged of the Hungarian Academy of Sciences) 
who originally lead the molecular part of the work.. 
In the following sections, we give a detailed account on the experimental work and the 
results.  
  
1. Isolation of intragenic deletion mutants for FMRFa and DMS-R1 
 
 
Genomic insertions of the P element transposon can be remobilized by the specific 
transposase. The „jumping out” of the transposon causes a double-strand DNA break, and 
the repair process can result in short deletions. By P transposon remobilization, we  isolated 
8 independent intragenic deletions in the dromyosuppressin-receptor 1 (DMS-R1) gene 
removing the first exon and partly the promoter region.,  and two deletions in the FMRFa 
gene, one deleting partly, the other entirely the peptide-coding region. Measuring the levels 
of the gene-specific mRNAs with RT-QPCR, we found deficiencies in both genes which 
apparenty eliminated the gene function. Despite of this, the homozygous mutant flies 
proved to be fully viable and fertile. In cooperation with Dr.Michal Žurovec (Inst. of 
Entomology, Czech Acad. Sci., České-Budejovice) we tested these mutants with respect to 
their basic metabolism (CO2 production) and moving activity in a startle-induced 
behavioral test. In the latter test, repeated air-puffs pushed the flies to one end of a glass 
tube, after which a computerized camera followed their locomotor activity through 3 
minutes, during which time the mean velocity of movement (MVM) values were calculated 
in short intervals. In the CO2 production, there was no difference between mutant and wild 
type adults. However, the mutants showed significantly less moving activity than the wild 
type suggesting that the FMRFa peptide and the DMS-R1 receptor are needed for the 
normal activity. 
 
 
2. RNAi silencing of FMRF-related peptides and receptors 
 
We have built an RNAi-based genetic system in which the FMRFa-related genes and their 
specific receptors could be silenced in pairwise combinations. For this, we used the RNAi 
stocks available for every annotated Drosophila gene from the VDRC RNAi Stock Center 
(Vienna; http://stockcenter.vdrc.at) and the NIGFly collection (Kyoto; 
http://www.shigen.nig.ac.jp/fly/nigfly/index.jsp). In these stocks the RNAi transgene is 
driven by the Gal4-inducible UAS promoter. The test combinations contained an UAS-
Dicer2 construct (on the X chromosome) to enhance the efficiency of the silencing effect, 
one or two UAS-RNAi constructs (2nd and/or 3rd chr., respectively) silencing different 
genes (a neuropeptide and/or its specific receptor or two related receptors) and a GAL4-
driver. We expected that the maximum silencing effect could be reached in combinations 
where the production of a neuropeptide and its specific receptor were simultaneously 
suppressed. 
In the first experiment, the RNAi stocks were crossed to the Act5C-Gal4 driver inducing a 
ubiquitous and continuous expression of the double-stranded RNA. As Table 1 shows, the 
silencing of certain genes resulted in complete lethality while others remained viable. The 
lethal effect was observed with the KK series of VDRC mutants where the  silencing 
construct is inserted into a standard „landing platform” in the 2nd chromosome ensuring a 
uniform strong expression. The same constructs inserted in the 3rd chromosome at 
accidental places (GD series) had no lethal effect, probably due to lower expression 
Because the main source of the neuropeptides are the neurons in the central nervous system 
(CNS), next we used the elav-Gal4 pan-neuronal driver to induce the RNAi effect. As the 
elav promoter expresses the Gal4 exclusively in the neurons, the RNAi silencing is 
confined to the CNS. In comparison with the results gained with the Act5-Gal4 driver, we 
hoped to decide which effect is dependent on the CNS and which comes from the 
periphery. We crossed the RNAi stocks listed in Table to the elav-Gal4 driver. To our 
surprise, all these genetic combinations were viable and fertile.  
Two logical explanations can be offered for this observation: (a) the lethality is induced by 
some ectopic (outside of CNS) expression of the RNAi effect induced by the Act5C-Gal4 
driver; (b) „off-target” RNAi effect, i.e. silencing non-specific genes which have sections in 
their DNA sequence similar to that of the target gene. In theory, neuropeptides can act 
outside of the CNS, and their receptors could be expressed on tissues on the periphery, but 
the data on the spatial expression of the receptors are rather limited. Therefore, we decided 
to examine the off-target effect in more detail. 
 
Table 1: Phenotypic effects of RNAi silencing of the FMRFa-related peptides and 
their receptors 
 
Silenced gene1 Construct I.D. number2 
(chromosomal location) 
Genetic combination F1 phenotype (25oC)3 
 
FMRFa KK 103981 (2)    L 
FR NIG 2114R-1 (3)  V 
DMS KK 108760 (2)  L 
DMS-R1 KK101845  (2) 
GD     9154  (3) 
   L4 
V 
DMS-R2 KK 109513 (2) 
GD    49953 (3) 
 n.d. 
V 
DSK KK 106592 (2)  V 
DSK-R1 KK 102039 (2) 
GD     9154 (3) 
 V 
V 
DSK-R2 KK 100760 (2) 
GD     7231 (3) 
  L 
 V 
FMRFa ; FR  103981;NIG 2114R-1  L 
DMS ; DMS-R2  108760 ; 49953 L 
DMS-R1 ; DMS-R2  101845 ; 49953 L 
DMS-R2 ; DMS-R1  109513 ; 9370 L 
DSK ; DSK-R2  106592 ; 7231 V 
DSK-R1 ; DSK-R2  102039 ; 7231 V 
DSK-R2 ; DSK-R1  100760 ; 9154  L 
 
1Abbreviations: 
n.d.=no data ; DMS=Dromyosuppressin peptide; DSK-R1,-R2=DMS-Receptor-1, -2; 
DSK=Drosulfakinin peptide; DSK-R1, -R2=DSK-Receptor-1, -2; 
FMRFa=FMRFa peptide; FR= FMRFa receptor; L=lethal; V=viable 
2KK and GD label VDRC stocks (http://stockcenter.vdrc.at); 
 NIG labels NIGFLY stock (http://www.shigen.nig.ac.jp/fly/nigfly/indec.jsp) 
3Crosses made at 18oC or 29oC gave results similar to those at 25o. 
4Few short-lived escapers at 18oC with distorted wings and disorganized    movement 
 
We took the possible off-target genes referring to the „target” genes in Table 1, the RNAi 
silencing of which yielded lethality (FMRFa, DMS, DMS-R1, DSK-R2). For this we took 
the off-target genes as suggested in the VDRC stock-list. In addition, we made a BLAST 
search of the Drosophila genome for genes having at least 10 nucleotide long DNA 
sequence stretches identical with the target gene. As shown in Table 2, all the four target 
genes have several off-target counterparts, and crossed to the Act5C-Gal4 driver the 
majority of the stocks gave lethality in the F1 generation. In fact, we found RNAi stocks for 
all the off-target genes which resulted in lethality in combination with the Act5C-Gal4 
driver. 
 
Table 2: RNAi effects of off-target genes induced by Act5C-Gal4 
 
RNAi effect  induced by  
Act5C-Gal4 driver3 Target 
gene 
VDRC 
Stock 
center 
ID# Off-target gene1 
Off-target gene 
Transcripts2 VDRC RNAi stocks for off-
target  gene4 
NIGFly RNAi 
stocks for off-
target  gene 
Bloomington 
TRiP stocks for 
off-target  gene 
 
Stock ID  
 
 
103981 
 
Transport 
 and golgi 
organization 
1 (Tango1) 
CG11098 
1. Identities = 19/19  
2. Identities = 13/13  
3’ UTR : none 
 
21594 (GD) 2 
 
 
 
11098R-2 
11098R-3 
 
0 
FMRF 
RNAi 
construct 
ID 
103629 
wishful 
thinking(wit)  
CG10776 
Identities = 22/24  
 (11/11) 
3’ UTR : none 
103808 (KK) 
865 (GD) 
42244 (GD) 
42245 (GD)  
 
10776R-1 
10776R-2 
 
25949 
DMS Stock ID  
 
108760 
 
shaker 
cognate 
isoform G 
and I 
CG43128 
Identities = 11/11  
3’ UTR : none 
13043 (GD)  
46887 (GD) 
46889 (GD)  
47632(GD)  
 
0 
 
25805 
discs large 1 
(dlg1) 
CG1725 
1. Identities = 17/19  
2. Identities =  12/12 
 
3’ UTR: yes 
 
 
 
1725R-1 
1725R-2 
25780 
31181 
31520 
31521 
33620 
33629 
34854 
35286 
35772 
CG2201 
 isoform A 
and B 
Identities = 11/11 
  
3’ UTR  yes 
 
108958 (KK)  
33502 (GD)  
 
 
0 
 
35403 
RNAi 
construct 
ID 
110955 
bride of 
sevenless 
protein gene 
(boss) 
CG8285 
1. Identities = 16/18  
2. Identities = 11/11 
3’ UTR : none 
 
4365 (GD)  
4366 (GD)  
 
8285R-1 
8285R-2 
 
29439) 
tenascin 
accessory, 
isoform E/H  
CG42338 
1. Identities = 15/17  
2. Identities = 13/14   
3. Identities = 12/12  
3’ UTR : none 
103298 (KK)  
105037 (KK)  
8322 (GD)  
32482 (GD)  
39244 (GD)  
39245 (GD)  
40134 (GD)  
 
0 
 
Stock ID 
 
 
101845 
 
musashi, 
isoform A/B 
(Msi)  
CG5099 
1. Identities = 11/11  
   2. Identities = 17/193’ 
3’ UTR: yes (2.)  
11784 (GD)  
44895 (GD)  
 
0 
 
0 
DmsR-
1 
RNAi 
construct 
ID 
109948 
 
CG1105  Identities = 20/20  3’ UTR : none 
105981 (KK)  
28305 (GD)  
28308 (GD)  
 
1105R-1 
1105R-3 
 
31084 
 31224 
ariadne-
2(ari-2)  
 CG5709 
Identities = 19/19  
3’ UTR : none 
0 
 
5709R-1 
5709R-3 
0 
Stock ID 
 
 
100760 
 
CG3649  
1. Identities = 21/22  
2. Identities = 18/18 
3’ UTR : none 
104762 (KK)  
3517 (GD)  
3518 (GD)   
 
3649R-1 
3649R-2 
 
0 
scratch (scrt)  
CG1130 
Identities = 23/25  
3’ UTR : none 
105201 (KK)  
41070 (GD)  
41071 (GD)  
 
1130R-2 
1130R-3 
 
27025 
DskR-2 
RNAi 
construct 
ID 
108482 Elastin-
like(Ela)  
CG7021 
Identities = 22/24  
3’ UTR : yes 
107366 (KK)  
16474 (GD)  
7021R-2 
7021R-3 
 
0 
 
 
Abbreviations: 1CG: annotation number of the gene (http://flybase.org) 
2Identities: section of perfect match (with the target gene) in the 
off-target nucleotide sequence (in the 3’UTR region: yes or 
not) 
3Meaning of colours: lethal; viable; not tested) 
4KK and GD: VDRC stocks with RNAi insertions ont he 2nd or 
3rd chromosome, resp. 
 
3. RNAi knock-down of the FMRF gene decreases the activity of the off-target companions 
 
Table 3 shows the results of an experiment which directly tested the effect of silencing the 
FMRF gene on the mRNA levels derived from the Tango 1 and wit genes. The RNAi 
sequence (664 nt) which codes for the dsRNA in the VDRC stock No. 103981 has two 
regions homologous with the Tango 1 and wit genes, respectively. The Tango 1-homology 
is 19 nt long with a 13 nt sequence of perfect match. The 24 nt wit homology has an 11 nt 
sequence with 100% identity. There is no homology in the 3’UTR regions. When the 
No.103981 stock is crossed to the Act5-Gal4 driver, the level of the FMRF mRNA drops to 
less than 1% of the control (Table 4, Templates 01 and 06, resp.). The output of Tango 1 
parallely drops to 47% albeit wit remains unchanged. When we silenced the wit gene 
(Template 03), FMRF and Tango 1outputs decreased to 19%.and 37%, respectively, so the 
effect is reciprocal. 
In another experiment (Template 05, Table 4), the apoptosis-inducing reaper (rpr) gene 
was expressed by the FMRF-Gal4 driver in the FMRF-producing neurons. This resulted in 
the death of these cells, and a serious decrease of the FMRF mRNA level. Again, this did 
not decrease (in fact, increased) the wit output. We have no data yet on the Tango 1 level in 
these animals. 
 
Table 3: Measuring off-target knock-down effect among the FMRF, Tango 1  and wit 
genes by RT-QPCR  
 
Template series log2 change Expression % 
Template_01 FMRF -6,9 0,837323 
Template_01 Tango 1 -1,07 47,6319 
Template_01 wit -0,04 97,26549 
Template_03 FMRF -2,375 19,27764 
Template_03 Tango -1,425 37,24194 
Template_03 wit -2,305 20,23606 
Template_05 FMRF -2,63 16,15441 
Template_05 Tango 1  n.d. 
Template_05 wit 0,36 128,3426 
Template_06 FMRF  100 
Template_06 Tango 1  100 
Template_06 wit  1         100 
 
 
4. Creating single peptide-specific mutations in the FMRFa gene by homologous 
tecombination 
 
 We wanted to apply the  S.I.R.T. method (“site-specific integrase mediated repeated 
targeting”) described by Gao et al. (2008) for inducing mutations by homologous 
recombination in the individual peptide-coding sequences of the FMRFa gene. In short, at 
first an attP attachment site for the phage phiC31 integrase is inserted in the vicinity of the 
gene of interest by homologous recombination. After that any modification of the gene can 
be  introduced by phiC31 integrase-mediated insertion of plasmids carrying an attB 
attachment site and the desired mutation. The integration results in a tandem duplication of 
the target locus, which has to be reduced to a single copy carrying the mutation, during the 
repair process induced with a DNA double-strand break. Although this work was slowed 
down by the other experiments (see later and above), and the very sad death of our late 
colleague and molecular biology expert Dr. Géza Ádám, we finished introducing the 
phiC31-specific attP landing sequence within the first intron of the FMRFa gene. However, 
we had to stop with the work  at this point.  
 
5. Selective elimination/RNAi silencing of FMRFa-related peptides and their receptors 
decreases the locomotor activity in Drosophila melanogaster 
 
Previous studies have already suggested that the FaRP peptides and receptors have 
myotropic effects (Nichols et al., 2002; Kahsai et al., 2010). The experiments described 
here address the effects exerted by the FaRP peptides on the locomotor activity of 
Drosophila adults. For this purpose, we used two genetic approaches: (i) RNAi silencing of 
FMRF-related peptides and their receptors (see above) and (ii) construction of new FMRF-
Gal4 drivers which represent specific parts of the FMRFa spatial expression in the CNS, 
and their application to remove the corresponding neural cells by reaper (rpr)-induced 
apoptosis.  
 
5.1.Construction of FMRFa expression pattern-specific Gal4 drivers 
 
Benveniste and Taghert (1999) described 5’ upstream DNA sequences regulating the spatial 
expression in the CNS of the FMRFa gene. When they cloned these DNA fragments into a 
vector upstream of the β-galactosidase gene, they found the staining pattern reproducing 
specific parts of the FMRFa spatial expression. Based on this information, we amplified three 
such DNA sequences by PCR, cloned them into the pBPGUw vector upstream to the Gal4 
coding sequence, and made transgenic Drosophila strains (RS8-Gal4, RS11-Gal4, RS17-Gal4) 
carrying these constructs on the 3rd chromosome in the attP „landing platform” providing a 
strong and uniform expression. By making use of the UAS-GFP reporter gene, we tested the 
Gal4 expression in these stocks. As it was shown by the GFP fluorescence and GFP-specific 
immuno-staining, the expression pattern in the larval CNS of RS8, RS11 and RS17 reproduced 
the patterns described by Benveniste and Taghert (1999) for the same regulatory sequences 
(Fig. 1). However, additional GFP-positive neurons were also detected in all the three cases, 
especially in RS8. This might be explained by the enhanced visibility of the GFP expression 
provided by the immuno-staining with GFP-specific antibody. Another difference between our 
constructs and those of Benveniste and Taghert (1999) was in the relative orientation of the 
cloned sequences. In all three constructs of ours the orientation of the regulatory DNA 
segment relative to the Gal4 coding part was the same as in the genomic sequence. In the case 
of Benveniste and Taghert, however, the regulatory sequences corresponding to RS8 and RS11 
were cloned in the reverse orientation. Benveniste and Taghert attributed the observed 
expression patterns to the effect of enhancers, the activity of which is not influenced by their 
relative position and polarity. However, the possible effect of other „non-enhancer” sequences 
in the cloned DNA segments might be sensitive to their polarity relative to the coding region, 
and this could also be responsible for the ectopic expression. Unraveling this problem needs 
further studies. 
 
5.2. RNAi silencing of FaRPs and FaRP receptors in the CNS can decrease locomotor 
activity 
 
Flies having the RNAi constructs for a FaRPs and their specific receptors were crossed to 
the elav-Gal4 driver strain. The offspring carrying the RNAi transgenes and the elav driver 
showed normal viability and fertility, and was subjected to the ReSH (Repetitive Startle-
induced Hyperactivity) test as described by Lebetsky et al. (2009). Briefly, the flies were 
transferred into glass tubes connected to a pressurized air container (5 bars). Then two air 
puffs were delivered in a 1 sec. interval which pushed the flies to the rear end of the tube 
closed with a fine mesh. The video-recording began 1 min. before the first air puff and 
lasted for 4 min. afterwards. To avoid the differences generated by the cyrcadian rhytm, the 
tests were made in late morning or early afternoon. Three cycles were made with each 
group of flies. Four experiments (each one repeated in 3 cycles) were performed with 
different flies of each genotype, i.e. 80 male or female flies for every genotype were tested 
altogether.  Based on the video records, the average velocity (mm/sec) of the flies was 
calculated by the Drosana custom computer program (developed by Stefan Kakaš) in 0.1-
0.2 sec intervals, and used to construct curves representing the changing mean velocity of 
movement (MVM) in time. 
The results are shown in Fig. 1 for the female flies. (Similar effects were observed with the 
males, data not shown.) In general, suppressing the FARPs and/or their receptors 
significantly decreased the mean velocity of movement (MVM) of the flies in all genetic 
combinations tested. The MVM decrease was manifested at both the resting activity before 
the air puffs, and the puff-induced activity. The largest difference between the RNAi-
reduced MVM and the control values was found when both DMS-receptors (DMS-R1 and 
DMS-R2) were silenced in parallel. As for the absolute values, three of the tested 
combinations (silencing transgenes on the 2nd; 3rd chromosomes: RNAi-DMS/elav;RNAi-
DMS-R2/+,  RNAi-DMS-R1/elav;RNAi-DMS-R2/+,  RNAi-DSK/elav;RNAi-DSK-R2/+) 
showed the largest MVM decrease. In the two other cases (RNAi-FMRFa; RNAi-FR and 
RNAi-DMS-R2; RNAi-DMS-R1) the MVM decrease was less. For the RNAi-DSK-R2; 
RNAi-DSK-R1 silencing combination, the difference from the controls was not so 
remarkable. 
As mentioned above, the tested transgenes on the 2nd chromosome (KK series of the 
VDRC Stock Center) are inserted in the attP2 platform and have an uniformly strong 
expression, while the transgenes on the 3rd chromosome (GD series) have a varying, 
probably weaker expression due to the varying position effects. Although both the RNAi-
DMS-R1/elav-Gal4;RNAi-DMS-R2/+ and RNAi-DMS-R2/elav-Gal4;RNAi-DMS-R1/+ 
combinations silenced the DMS-R1 and DMS-R2 genes together (Fig. 1, C and D), the 
MVM effect was stronger when the RNAi-DMS-R1 transgene was inserted in the attP2 
platform on the 2nd chromosome and the RNAi-DMS-R2 on the 3rd (Fig. 1, C and D). The 
difference in the chromosomal position effects may be responsible for the variation 
between the MVM curves. These results show that, at least in the combinations tested, the 
FaRPs and their receptors can modify the locomotion activity and stress response of the 
fruitfly adults. 
 
5.3. Selective elimination of FMRFa peptiderg neurons in the CNS and its effect on the 
locomotor activity. 
 
To induce the targeted elimination of FMRFa-positive neurons, males of the RS8, RS11, 
RS17 and FMRF-Gal4 driver stocks were crossed to females of the UAS-rpr (X 
chromosome) transgenic strain. The elevated expression of the wild-type rpr gene induced 
apoptotic death of the neural cells (cf. Table 3, Template 5). The offspring carrying the 
RS11, RS17 or FMRF-Gal4 drivers together with UAS-rpr developed normally, and 
resulted normal adults. However, a good part of the UAS-rpr/Y;RS8/+ males and UAS-
rpr/+;RS8/+ females died as pharate adults. About 20% of the surviving flies had distorted 
wings, moved uncoordinately, and died within 2-3 days after eclosion.  
The flies transheterozygous for the Gal4 drivers and UAS-rpr were subjected to the ReSH 
test. The results are shown in Fig.3 for the females. Of the UAS-rpr/+; RS8-Gal4/+ 
females, only flies with normal wings were selected for the test. As Fig.3A shows, these 
flies showed a low pre-puff activity which was only slightly elevated by the air puffs. 
Interestingly, the usual MVM peak instant with the puffs was missing in this case. 
Examining the video-recordings showed that the flies mostly flocked together at the rear 
end of the tube, and did not move much upon and following the air puffs. On the contrary, 
the activity of the UAS-rpr/Y;RS8-Gal4/+; males was unexpectedly close to the control (not 
shown). This would mean that the RS8-Gal4-induced neuronal ablation interfered with the 
regulation of the startle-induced locomotor response in some gender-specific way. 
We further examined the locomotor activity of the „sluggish”  UAS-rpr/+; RS8-Gal4/+ 
females in the negative geotaxis test. Briefly, the flies were transferred into glass tubes of 
vertical position, and were shaken off by knocking the rack twice to the table manually. 
Leaving the tube in vertical position, photographs were taken after 10, 20  and 30  seconds, 
and the flies were counted according to their distribution by height along the tube.  
The results are shown in Fig. 4. Interestingly, the flies were just as active as the controls. 
This may mean that the startle-induced locomotor activity and the negative geotaxis are 
differently regulated in the UAS-rpr/+; RS8-Gal4/+ female flies. 
The other female combination which showed a remarkable decrease in the puff-induced 
MVM was UAS-rpr/+;RS17/+ (Fig. 3). As for the remaining two combinations, UAS-
rpr/+;RS11/+  and UAS-rpr/+;FMRF-Gal4/+ coincided with the control activities (Fig. 3, 
B and D, resp.). 
In the male combinations, UAS-rpr/Y;RS8/+ and UAS-rpr/Y;RS11/+ were not significantly 
different from the controls. The UAS-rpr/Y;RS17/+ combination only moderately decreased 
the MVM, while the behavior of UAS-rpr/Y;FMRF-Gal4/+  flies was  indistinguishable 
from the controls. 
The above experiments resulted in several unexpected observations. First of all, the 
completely normal activity and behavior of the flies carrying the UAS-rpr and FMRF-Gal4 
transgenes was a surprise. In these flies all the FMRF-producing neurons are most likely 
missing, consequently the level of the FMRFa peptides is very low (see Table 3, Template 
5). (It has to be noted, however, that in this case the activity of the FR receptor is still 
normal.) On the other hand, when the RS8, RS11 and RS17 drivers were used to drive the 
expression of UAS-rpr, only specific parts of the FMRF-expressing neuronal pattern were 
ablated, and yet it influenced the flies’ locomotor activity (see 5.3. as well as Fig. 3). Also, 
when the genes coding for the FMRFa peptides and the specific FR receptor were silenced 
together, the MVM of the flies became much lower than that of the control (see 5.2. and 
Fig. 2). In the light of these findings, the ineffectiveness of the UAS-rpr;FMRF-Gal4 
combination, where the FMRFa-producing neurons have been killed, is enigmatic. One can 
speculate that the neurons activated in the FMRF-Gal4 expression pattern are in some kind 
of balance, so when the whole pattern is missing, the lacking parts could neutralize each 
other’s effects. This notion may be supported by the observation that in the RS8, RS11 and 
RS17 drivers the Gal4 is expressed in extra neurons which are outside of the previously 
described (Benveniste and Taghert, 1999) FMRF pattern, and might interfere with this 
hypothetical balance leading to the low MVM phenotype. In this respect, the RS8 driver 
activates most of the extra neurons (Fig.1, D). Furthermore, in the UAS-rpr;RS8 
combination the high incidence of pharate adult lethality and the distorted wing phenotype 
suggest that the RS8 driver can express the Gal4 in other tissues as well outside of the CNS, 
e.g. in the wing imaginal disc epithelium. All these may mean that if a partial sequence is 
taken out of the original context of a regulatory region, ectopic new activities may arise. 
 
Closing remark:  The above results were summarized in a manuscript which has been 
submitted for publication: 
Brigitta Kiss, Tamás Szlanka, Beáta Ramasz, Zoltán Hegedűs, Michal Žurovec, 
Michal Sery, Štefan Kakas, Tamás Lukacsovich, Adrien Fónagy and István Kiss: 
 
Selective elimination/RNAi silencing of FMRFa-related peptides and their receptors 
decreases the locomotor activity in Drosophila melanogaster 
(Gen. Comp. Endocrinology, submitted) 
 
The above article as well as another one on the off-target effects will be published during the 
next two years. Therefore, we respectfully ask the OTKA Committee to take this fact into 
consideration when evaluating this closing report on OTKA Grant No. 75774. 
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Figure1: Transcription activating patterns of different regulatory sequences (A-C: 
RS11, D-F: RS8 and G-I:  RS17) of the FMRFa gene in the larval CNS. 
Confocal micrographs (A, D and G) and their schematic representations (B, 
E and H) of immuno-stained UAS-GFP expressing cells in the brain and the 
ventral ganglia of third instar larvae.  Schematic representations of beta-
galactosidase expressions (C, F and I) in larval CNS, controlled by RS11, 
RS8 and RS17 (after Benveniste and Taghert, 1999). Positions of the 
regulatory sequences within the FMRFa gene 5’ region and their 
orientations relative to the reporter genes in the two different types of testing 
constructs are depicted above each schematic panel. In the schematics red 
and green points represent FMRFa-positive neurons described by 
Benveniste and Taghert (1999) and/or observed in this study, respectively.  
 
 
 
Figure 2: RNAi knock-down of FaRP and FaRP-receptor genes effectively changes 
the startle (air puff)-induced locomotor activity of Drosophila females. The 
curves represent the changes in time of the mean  velocity of movement 
(MVM) before and after the air-puffs. Blue and green: control curves; red: 
RNAi knock-down curve.Fly genotypes are indicated in the upper right 
corner of each panel. (Abbreviations: Dcr=Dicer; i=UAS-RNAi, Gal4-
inducible transgene producing double-stranded RNA; elav=elav-Gal4 
driver) 
 
Figure 3: Ablating subsets of FMRFa-producing neural cells in the CNS may 
influence the startle (air puff)-induced locomotor activity of Drosophila 
females. The ablating effect is targeted by RS-Gal4 drivers which induce the 
apoptotic UAS-rpr transgene. The curves represent the changes in time of 
the mean  velocity of movement (MVM) before and after the air-puffs.  Blue  
and green: control curves; red: ablation effect curve. Fly genotypes are 
indicated in the upper right corner of each panel. (Abbreviations: RS8, 
RS11, RS17=regulatory sequences from the 5’ region of the FMRFa gene; 
rpr=UAS-reaper transgene.) 
 
 
 
 
Figure 4: RS8-Gal4-induced ablation of specific FMRFa-producing neurons does not 
affect the negative geotaxis of female flies. The bars represent the average 
number of flies climbed up above the 95 mm threshold level. Blue and 
green: controls; red: ablation effect. Fly genotypes are indicated in the 
upper right corner. (Abbreviations: RS8=regulatory sequence from the 5’ 
region of the FMRFa gene; rpr=UAS-reaper transgene.) 
 
